Company Profile
Vivos Therapeutics Stock Price, News & Analysis
- Ticker:
- VVOS
- Exchange:
- NASDAQ
- Sector:
- Biopharma
- Location:
- United States
Stock performance
0.32 USD (-5.46%)
Close
Last updated: August 6, 2026
9.42M USD
Market cap
Why the stock is moving
Following the latest company update, “Vivos Therapeutics Announces Issuance of New US Patent Broadening Protection for Its Vivos CARE Oral Medical Device Technology”, VVOS closed down 26.3% at $0.3406 on Aug 5, 2026. The move occurred in the trading session associated with this company update.
Company overview
Sleep-Disordered Breathing Technology
Vivos Therapeutics is a medical technology and healthcare-services company focused on obstructive sleep apnea, snoring, and related chronic conditions. It combines oral appliances, diagnostic workflows, and sleep-center partnerships to improve identification and treatment of OSA.
CARE Devices and the Vivos Method
The company’s Complete Airway Repositioning and Expansion devices have received FDA 510(k) clearance for adults across OSA severity levels and for moderate-to-severe OSA in children ages six through 17. Vivos integrates these devices with clinical protocols through the Vivos Method.
Provider and Sleep-Center Integration
Vivos works with dentists, physicians, and sleep centers to identify patients and deliver treatment. The acquisition of The Sleep Center of Nevada gives the company a direct clinical-services platform alongside its device business.
Service-Enabled Commercial Model
Revenue opportunities include oral-appliance sales, clinical education, diagnostic and sleep services, and support for insurance reimbursement. This model combines medical technology with a provider network rather than relying solely on standalone device sales.
Future catalysts
Vivos Therapeutics’s catalysts are sleep-apnea device adoption, reimbursement, and broader dental-sleep workflow penetration. The story improves as the installed base becomes more durable.
Recent news
- 01
- 02
- 03
- 04
Vivos Therapeutics Announces Intent to File a Registration Statement for a Proposed Rights Offering
Source: Vivos Therapeutics
- 05
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Vivos Therapeutics (VVOS)?
Vivos Therapeutics (VVOS) most recently closed at 0.32 USD, a -5.46% move versus the previous session.
What is the market cap of Vivos Therapeutics (VVOS)?
Vivos Therapeutics currently has a market capitalization of 9.42M USD on BioPharmSignal.
What does Vivos Therapeutics do?
Sleep-Disordered Breathing Technology Vivos Therapeutics is a medical technology and healthcare-services company focused on obstructive sleep apnea, snoring, and related chronic conditions. It combines oral appliances, diagnostic workflows, and sleep-center partnerships to improve identification and treatment of OSA. CARE Devices and the Vivos Method The...
On which exchange is VVOS stock listed?
Vivos Therapeutics (VVOS) is associated with NASDAQ, United States, Biopharma.
What is Sleep-Disordered?
Sleep-Disordered Breathing Technology Vivos Therapeutics is a medical technology and healthcare-services company focused on obstructive sleep apnea, snoring, and related chronic conditions.
Which conditions is Vivos Therapeutics targeting with Sleep-Disordered?
Sleep-Disordered Breathing Technology Vivos Therapeutics is a medical technology and healthcare-services company focused on obstructive sleep apnea, snoring, and related chronic conditions. It combines oral appliances, diagnostic workflows, and sleep-center partnerships to improve identification and treatment of OSA. CARE Devices and the Vivos Method The...
How does Vivos Therapeutics describe recent progress with Sleep-Disordered?
Vivos Therapeutics’s catalysts are sleep-apnea device adoption, reimbursement, and broader dental-sleep workflow penetration. The story improves as the installed base becomes more durable.
What is Breathing?
Sleep-Disordered Breathing Technology Vivos Therapeutics is a medical technology and healthcare-services company focused on obstructive sleep apnea, snoring, and related chronic conditions.